L. D. Johns

Transforming growth factor-β1 differentially regulates proliferation and MHC class-II antigen expression in forebrain and brainstem astrocyte primary cultures

M. Freedman, R. Ransohoff, S. Sriram, 1992, Brain Research.

Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1.

K. Flanders, S. Sriram, S. Sriram, 1991, Journal of immunology.

Experimental allergic encephalomyelitis: Neutralizing antibody to TGFβ1 enhances the clinical severity of the disease

S. Sriram, L. D. Johns, 1993, Journal of Neuroimmunology.

Prophylactic exposure to oral riluzole reduces the clinical severity and immune-related biomarkers of experimental autoimmune encephalomyelitis

R. Rotolo, A. Betz, L. D. Johns, 2021, Journal of Neuroimmunology.

Inhibition of ceramide pathway does not affect ability of TNF-alpha to activate nuclear factor-kappa B.

G. Ranges, L. D. Johns, T. Sarr, 1994, Journal of immunology.